retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Retatrutide, a GIP, and receptor Beyond GLP-1: Retatrutide's triple-agonist mechanism
Pay in 4 interest-free payments of $7.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



























